☰

Lalita Subramanian, Ph.D. - Publications

Affiliations: 
2005 University of Wisconsin, Madison, Madison, WI 
Area:
Biochemistry, Oncology, Molecular Biology
Tree Info Similar researchers PubMed Report error

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2011 Kenealey JD, Subramanian L, Van Ginkel PR, Darjatmoko S, Lindstrom MJ, Somoza V, Ghosh SK, Song Z, Hsung RP, Kwon GS, Eliceiri KW, Albert DM, Polans AS. Resveratrol metabolites do not elicit early pro-apoptotic mechanisms in neuroblastoma cells. Journal of Agricultural and Food Chemistry. 59: 4979-86. PMID 21401048 DOI: 10.1021/Jf104901G  0.696
2011 Soto BL, Hank JA, Van De Voort TJ, Subramanian L, Polans AS, Rakhmilevich AL, Yang RK, Seo S, Kim K, Reisfeld RA, Gillies SD, Sondel PM. The anti-tumor effect of resveratrol alone or in combination with immunotherapy in a neuroblastoma model. Cancer Immunology, Immunotherapy : Cii. 60: 731-8. PMID 21340652 DOI: 10.1007/S00262-011-0971-0  0.67
2010 Subramanian L, Youssef S, Bhattacharya S, Kenealey J, Polans AS, van Ginkel PR. Resveratrol: challenges in translation to the clinic--a critical discussion. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 5942-8. PMID 21045084 DOI: 10.1158/1078-0432.Ccr-10-1486  0.673
2008 van Ginkel PR, Darjatmoko SR, Sareen D, Subramanian L, Bhattacharya S, Lindstrom MJ, Albert DM, Polans AS. Resveratrol inhibits uveal melanoma tumor growth via early mitochondrial dysfunction. Investigative Ophthalmology & Visual Science. 49: 1299-306. PMID 18385041 DOI: 10.1167/Iovs.07-1233  0.704
2007 van Ginkel PR, Sareen D, Subramanian L, Walker Q, Darjatmoko SR, Lindstrom MJ, Kulkarni A, Albert DM, Polans AS. Resveratrol inhibits tumor growth of human neuroblastoma and mediates apoptosis by directly targeting mitochondria. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 5162-9. PMID 17785572 DOI: 10.1158/1078-0432.Ccr-07-0347  0.712
2004 Subramanian L, Crabb JW, Cox J, Durussel I, Walker TM, van Ginkel PR, Bhattacharya S, Dellaria JM, Palczewski K, Polans AS. Ca2+ binding to EF hands 1 and 3 is essential for the interaction of apoptosis-linked gene-2 with Alix/AIP1 in ocular melanoma. Biochemistry. 43: 11175-86. PMID 15366927 DOI: 10.1021/Bi048848D  0.613
2004 Subramanian L, Polans AS. Cancer-related diseases of the eye: the role of calcium and calcium-binding proteins. Biochemical and Biophysical Research Communications. 322: 1153-65. PMID 15336963 DOI: 10.1016/J.Bbrc.2004.07.109  0.647
2004 van Ginkel PR, Gee RL, Shearer RL, Subramanian L, Walker TM, Albert DM, Meisner LF, Varnum BC, Polans AS. Expression of the receptor tyrosine kinase Axl promotes ocular melanoma cell survival. Cancer Research. 64: 128-34. PMID 14729616 DOI: 10.1158/0008-5472.Can-03-0245  0.68
2002 Walker TM, Van Ginkel PR, Gee RL, Ahmadi H, Subramanian L, Ksander BR, Meisner LF, Albert DM, Polans AS. Expression of angiogenic factors Cyr61 and tissue factor in uveal melanoma. Archives of Ophthalmology (Chicago, Ill. : 1960). 120: 1719-25. PMID 12470148 DOI: 10.1001/Archopht.120.12.1719  0.588
Show low-probability matches.